Karolina Partheen

647 total citations
18 papers, 499 citations indexed

About

Karolina Partheen is a scholar working on Reproductive Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Karolina Partheen has authored 18 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Karolina Partheen's work include Ovarian cancer diagnosis and treatment (14 papers), Genomic variations and chromosomal abnormalities (4 papers) and Cancer Genomics and Diagnostics (3 papers). Karolina Partheen is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Genomic variations and chromosomal abnormalities (4 papers) and Cancer Genomics and Diagnostics (3 papers). Karolina Partheen collaborates with scholars based in Sweden and Belgium. Karolina Partheen's co-authors include Kristina Levan, Karin Sundfeldt, Björg Kristjánsdóttir, Lovisa Österberg, György Horváth, Khalil Helou, Björn Olsson, Elisabet Carlsohn, G. Horváth and Ulla Delle and has published in prestigious journals such as International Journal of Cancer, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Karolina Partheen

18 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karolina Partheen Sweden 13 235 227 168 96 74 18 499
Kristina Levan Sweden 14 178 0.8× 223 1.0× 150 0.9× 106 1.1× 47 0.6× 17 463
Jonathan G. Bijron United States 8 437 1.9× 235 1.0× 141 0.8× 164 1.7× 156 2.1× 13 667
Lindsay Bergan United States 9 425 1.8× 157 0.7× 106 0.6× 102 1.1× 170 2.3× 12 655
Cindy A. Pise-Masison United States 5 371 1.6× 497 2.2× 320 1.9× 158 1.6× 65 0.9× 6 820
Eva Glud Denmark 13 272 1.2× 196 0.9× 100 0.6× 244 2.5× 81 1.1× 15 523
Tuulia Vallius United States 8 121 0.5× 129 0.6× 84 0.5× 160 1.7× 67 0.9× 16 405
Nirupa Murugaesu United Kingdom 10 167 0.7× 277 1.2× 197 1.2× 185 1.9× 17 0.2× 16 648
Grażyna Ewa Będkowska Poland 13 92 0.4× 166 0.7× 190 1.1× 171 1.8× 41 0.6× 29 433
Tasuku Mariya Japan 11 63 0.3× 257 1.1× 117 0.7× 227 2.4× 63 0.9× 47 536
Karen Sayal United Kingdom 5 209 0.9× 225 1.0× 362 2.2× 175 1.8× 15 0.2× 7 570

Countries citing papers authored by Karolina Partheen

Since Specialization
Citations

This map shows the geographic impact of Karolina Partheen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolina Partheen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolina Partheen more than expected).

Fields of papers citing papers by Karolina Partheen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolina Partheen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolina Partheen. The network helps show where Karolina Partheen may publish in the future.

Co-authorship network of co-authors of Karolina Partheen

This figure shows the co-authorship network connecting the top 25 collaborators of Karolina Partheen. A scholar is included among the top collaborators of Karolina Partheen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolina Partheen. Karolina Partheen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kristjánsdóttir, Björg, Karolina Partheen, Eric T. Fung, et al.. (2014). Early inflammatory response in epithelial ovarian tumor cyst fluids. Cancer Medicine. 3(5). 1302–1312. 12 indexed citations
2.
Kristjánsdóttir, Björg, Kristina Levan, Karolina Partheen, & Karin Sundfeldt. (2013). Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer. Gynecologic Oncology. 131(1). 52–58. 62 indexed citations
3.
Kristjánsdóttir, Björg, Kristina Levan, Karolina Partheen, Elisabet Carlsohn, & Karin Sundfeldt. (2013). Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ. Clinical Proteomics. 10(1). 4–4. 33 indexed citations
4.
Kristjánsdóttir, Björg, Karolina Partheen, Eric T. Fung, et al.. (2012). Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers. Clinical Proteomics. 9(1). 14–14. 31 indexed citations
5.
Samuelson, Emma, et al.. (2012). BAC CGH-array identified specific small-scale genomic imbalances in diploid DMBA-induced rat mammary tumors. BMC Cancer. 12(1). 352–352. 5 indexed citations
6.
Partheen, Karolina, Björg Kristjánsdóttir, & Karin Sundfeldt. (2011). Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass. Journal of Gynecologic Oncology. 22(4). 244–244. 71 indexed citations
7.
Levan, Kristina, Karolina Partheen, Lovisa Österberg, et al.. (2010). Identification of a Gene Expression Signature for Survival Prediction in Type I Endometrial Carcinoma. Gene Expression. 14(6). 361–370. 11 indexed citations
8.
Elgqvist, Jörgen, Bengt R. Johansson, Karolina Partheen, & Anna Danielsson. (2010). Tumor cure probability during alpha-RIT of ovarian cancer with different radiation sensitivity.. PubMed. 30(7). 2545–51. 4 indexed citations
9.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2010). Specific copy number alterations associated with docetaxel/carboplatin response in ovarian carcinomas.. PubMed. 30(11). 4451–8. 10 indexed citations
10.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2009). Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas. BMC Cancer. 9(1). 368–368. 27 indexed citations
11.
Partheen, Karolina, et al.. (2009). External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas. BMC Cancer. 9(1). 336–336. 15 indexed citations
12.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, et al.. (2009). High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma. Cytogenetic and Genome Research. 125(1). 8–18. 15 indexed citations
13.
Partheen, Karolina, et al.. (2008). Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. International Journal of Cancer. 123(9). 2130–2137. 66 indexed citations
14.
Levan, Kristina, Karolina Partheen, Lovisa Österberg, Khalil Helou, & G. Horváth. (2006). Chromosomal alterations in 98 endometrioid adenocarcinomas analyzed with comparative genomic hybridization. Cytogenetic and Genome Research. 115(1). 16–22. 20 indexed citations
15.
Österberg, Lovisa, et al.. (2006). Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas. Cancer Genetics and Cytogenetics. 167(2). 103–108. 13 indexed citations
16.
Partheen, Karolina, Kristina Levan, Lovisa Österberg, & György Horváth. (2006). Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. European Journal of Cancer. 42(16). 2846–2854. 44 indexed citations
17.
Österberg, Lovisa, Kristina Levan, Karolina Partheen, Khalil Helou, & György Horváth. (2005). Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma. Cancer Genetics and Cytogenetics. 163(2). 144–150. 25 indexed citations
18.
Partheen, Karolina, Kristina Levan, Lovisa Österberg, Khalil Helou, & György Horváth. (2004). Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage. Genes Chromosomes and Cancer. 40(4). 342–348. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina Levan Breakdown of academic impact, for papers by Jonathan G. Bijron Breakdown of academic impact, for papers by Lindsay Bergan Breakdown of academic impact, for papers by Cindy A. Pise-Masison Breakdown of academic impact, for papers by Eva Glud Breakdown of academic impact, for papers by Tuulia Vallius Breakdown of academic impact, for papers by Nirupa Murugaesu Breakdown of academic impact, for papers by Grażyna Ewa Będkowska Breakdown of academic impact, for papers by Tasuku Mariya Breakdown of academic impact, for papers by Karen Sayal
Rankless by CCL
2026